Skip to main
FRLN
FRLN logo

Freeline Therapeutics Holdings (FRLN)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy FRLN Stock

About Freeline Therapeutics Holdings (FRLN)

Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom.
Market cap$28.24M
Today's volume
Revenue (TTM)
Avg. daily volume
EBITDA (TTM)
Open
Price / earnings ratio
Today's range
Debt / equity
52 week range$6.48 - $6.48
5 year debt / equity
Beta (LTM)
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsDec 1, 2023
Dividend payable date

FRLN Stock Rating

What analysts recommend for FRLN stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 33%
Buy 22%
Hold 44%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 15, 2025, the market cap for FRLN stock is $28.24M

The 52-week high for FRLN stock is $6.48. The current FRLN stock price $undefined is 100.00% below its 52-week high

The 52-week low for FRLN stock is $6.48. The current FRLN stock price $undefined has increased 100.00% from its 52-week low

No, the FRLN stock does not pay dividends to its shareholders

The target price for FRLN stock is $14.06 based on the average of what a group of analyst think FRLN stock could be worth at a future date. This is not a prediction by Public.com

How to buy FRLN stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in FRLN stock

    Navigate to the Explore page. Then, type FRLN into the search bar. When you see FRLN stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased FRLN stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Freeline Therapeutics Holdings Stock Earnings

The value each FRLN share was expected to gain vs. the value that each FRLN share actually gained.

FRLN (FRLN) reported Q3 2023 earnings per share (EPS) of -$0.18, beating estimates of -$0.71 by 74.65%. In the same quarter last year, FRLN's earnings per share (EPS) was -$3. FRLN is expected to release next earnings on 12/01/2023, with an earnings per share (EPS) estimate of $0.

Buy FRLN Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.